Moreover, high concentrations of ascorbate were able to downregulate the phosphorylation of FLT3 and its downstream target proteins STAT5a/b, suggesting the potential activity of the drug also in the subset of FLT3-ITD positive AML. Here, FLT3 is linked to acute myeloid leukemia.